Kyrgyzstan vs Serbia: Number of deaths from cardiovascular diseases by type
Kyrgyzstan
105.78 deaths
in 2021
Serbia
113.03 deaths
in 2021
Kyrgyzstan rank
97th
Serbia rank
95th
Number of deaths from cardiovascular diseases by type over time
- Kyrgyzstan
- Serbia
How they compare
Serbia currently reports 113.03 deaths against 105.78 deaths in Kyrgyzstan, a difference of 7.25 deaths.
That makes Serbia's figure about 1.1 times Kyrgyzstan's.
The two have swapped places 3 times across 22 shared years of data; in 2000 it was Kyrgyzstan ahead.
Kyrgyzstan ranks 97th and Serbia ranks 95th of 194 countries.
Across the 3 decades both report, Kyrgyzstan averaged higher in 2 and Serbia in 1.
Head to head by decade
| Decade | Kyrgyzstan | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 268.52 deaths | 113.19 deaths | 155.32 deaths | Kyrgyzstan |
| 2010s | 170.33 deaths | 96.96 deaths | 73.37 deaths | Kyrgyzstan |
| 2020s | 112.34 deaths | 131.26 deaths | 18.92 deaths | Serbia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of deaths from cardiovascular diseases by type, Kyrgyzstan or Serbia?
- Serbia, at 113.03 deaths against 105.78 deaths in Kyrgyzstan as of 2021.
- What is the difference in number of deaths from cardiovascular diseases by type between Kyrgyzstan and Serbia?
- 7.25 deaths, with Serbia ahead.
- How many years of comparable data are there for Kyrgyzstan and Serbia?
- 22 years are reported by both, from 2000 to 2021.
- How do Kyrgyzstan and Serbia rank globally for number of deaths from cardiovascular diseases by type?
- Kyrgyzstan ranks 97th and Serbia ranks 95th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Number of deaths from cardiovascular diseases by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from rheumatic heart disease in both sexes.